References
- Prentice AM. The emerging epidemic of obesity in developing countries. Int J Epidemiol 2006; 35:93–9; PMID: 16326822; https://doi.org/10.1093/ije/dyi272
- Roubenoff R, Roubenoff RA, Ward LM, Holland SM, Hellmann DB. Rheumatoid cachexia: depletion of lean body mass in rheumatoid arthritis. Possible association with tumor necrosis factor. J Rheumatol 1992; 19:1505–10.
- Giles JT, Ling SM, Ferrucci L, Bartlett SJ, Andersen RE, Towns M, Muller D, Fontaine KR, Bathon JM. Abnormal body composition phenotypes in older rheumatoid arthritis patients: association with disease characteristics and pharmacotherapies. Arthritis Rheum 2008; 59:807–15; PMID: 18512711; https://doi.org/10.1002/art.23719
- Binymin K, Herrick A, Carlson G, Hopkins S. The effect of disease activity on body composition and resting energy expenditure in patients with rheumatoid arthritis. J Inflamm Res 2011; 4:61–6; PMID: 22096370; https://doi.org/10.2147/JIR.S16508
- Sandberg ME, Bengtsson C, Kallberg H, Wesley A, Klareskog L, Alfredsson L, Saevarsdottir S. Overweight decreases the chance of achieving good response and low disease activity in early rheumatoid arthritis. Ann Rheum Dis 2014; 73:2029–33; PMID: 24818635; https://doi.org/10.1136/annrheumdis-2013-205094
- Heimans L, van den Broek M, le Cessie S, Siegerink B, Riyazi N, Han KH, Kerstens PJ, Huizinga TW, Lems WF, Allaart CF. Association of high body mass index with decreased treatment response to combination therapy in recent-onset rheumatoid arthritis patients. Arthritis Care Res (Hoboken) 2013; 65:1235–42; PMID: 23408767; https://doi.org/10.1002/acr.21978
- Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 1995; 95:2409–15; PMID: 7738205; https://doi.org/10.1172/JCI117936
- Stavropoulos-Kalinoglou A, Metsios GS, Panoulas VF, Douglas KM, Nevill AM, Jamurtas AZ, Kita M, Koutedakis Y, Kitas GD. Associations of obesity with modifiable risk factors for the development of cardiovascular disease in patients with rheumatoid arthritis. Ann Rheum Dis 2009; 68:242–5; PMID: 18677010; https://doi.org/10.1136/ard.2008.095596
- Szasz T, Webb RC. Perivascular adipose tissue: more than just structural support. Clin Sci (Lond) 2012; 122:1–12; PMID: 21910690; https://doi.org/10.1042/CS20110151
- Cinti S. The adipose organ. Prostaglandins Leukot Essent Fatty Acids 2005; 73:9–15; PMID: 15936182; https://doi.org/10.1016/j.plefa.2005.04.010
- Seale P, Bjork B, Yang W, Kajimura S, Chin S, Kuang S, Scime A, Devarakonda S, Conroe HM, Erdjument-Bromage H, et al. PRDM16 controls a brown fat/skeletal muscle switch. Nature 2008; 454:961–7; PMID: 18719582; https://doi.org/10.1038/nature07182
- Chatterjee TK, Aronow BJ, Tong WS, Manka D, Tang Y, Bogdanov VY, Unruh D, Blomkalns AL, Piegore MG, Jr., Weintraub DS, et al. Human coronary artery perivascular adipocytes overexpress genes responsible for regulating vascular morphology, inflammation, and hemostasis. Physiol Genomics 2013; 45:697–709; PMID: 23737535; https://doi.org/10.1152/physiolgenomics.00042.2013
- Ohashi K, Ouchi N, Matsuzawa Y. Adiponectin and hypertension. Am J Hypertens 2011; 24:263–9; PMID: 20930707; https://doi.org/10.1038/ajh.2010.216
- Rajsheker S, Manka D, Blomkalns AL, Chatterjee TK, Stoll LL, Weintraub NL. Crosstalk between perivascular adipose tissue and blood vessels. Curr Opin Pharmacol 2010; 10:191–6; PMID: 20060362; https://doi.org/10.1016/j.coph.2009.11.005
- Yamawaki H. Vascular effects of novel adipocytokines: focus on vascular contractility and inflammatory responses. Biol Pharm Bull 2011; 34:307–10; https://doi.org/10.1248/bpb.34.307
- Gao YJ, Lu C, Su LY, Sharma AM, Lee RM. Modulation of vascular function by perivascular adipose tissue: the role of endothelium and hydrogen peroxide. Br J Pharmacol 2007; 151:323–31; PMID: 17384669; https://doi.org/10.1038/sj.bjp.0707228
- Ketonen J, Shi J, Martonen E, Mervaala E. Periadventitial adipose tissue promotes endothelial dysfunction via oxidative stress in diet-induced obese C57Bl/6 mice. Circ J 2010 ; 74:1479–87; PMID: 20526041; https://doi.org/10.1253/circj.CJ-09-0661
- Villacorta L, Chang L. The role of perivascular adipose tissue in vasoconstriction, arterial stiffness, and aneurysm. Horm Mol Biol Clin Investig 2015; 21:137–47; PMID: 25719334; https://doi.org/10.1515/hmbci-2014-0048
- Hausman DB, DiGirolamo M, Bartness TJ, Hausman GJ, Martin RJ. The biology of white adipocyte proliferation. Obes Rev 2001; 2:239–54; PMID: 12119995; https://doi.org/10.1046/j.1467-789X.2001.00042.x
- Cousin B, Munoz O, Andre M, Fontanilles AM, Dani C, Cousin JL, Laharrague P, Casteilla L, Penicaud L. A role for preadipocytes as macrophage-like cells. FASEB J 1999; 13:305–12. PMID: 9973318
- Owen MK, Witzmann FA, McKenney ML, Lai X, Berwick ZC, Moberly SP, Alloosh M, Sturek M, Tune JD. Perivascular adipose tissue potentiates contraction of coronary vascular smooth muscle: influence of obesity. Circulation 2013; 128:9–18; PMID: 23685742; https://doi.org/10.1161/CIRCULATIONAHA.112.001238
- Szasz T, Bomfim GF, Webb RC. The influence of perivascular adipose tissue on vascular homeostasis. Vasc Health Risk Manag 2013; 9:105–16; PMID: 23576873; https://doi.org/10.2147/VHRM.S33760
- Reynolds S, Williams AS, Williams H, Smale S, Stephenson HJ, Amos N, George SJ, O'Donnell VB, Lang D. Contractile, but not endothelial, dysfunction in early inflammatory arthritis: a possible role for matrix metalloproteinase-9. Br J Pharmacol 2012; 167:505–14; PMID: 22506619; https://doi.org/10.1111/j.1476-5381.2012.01988.x
- Greenstein AS, Khavandi K, Withers SB, Sonoyama K, Clancy O, Jeziorska M, Laing I, Yates AP, Pemberton PW, Malik RA, et al. Local inflammation and hypoxia abolish the protective anticontractile properties of perivascular fat in obese patients. Circulation 2009; 119:1661–70; PMID: 19289637; https://doi.org/10.1161/CIRCULATIONAHA.108.821181
- Sanchez-Gurmaches J, Hung CM, Guertin DA. Emerging complexities in Adipocyte origins and identity. Trends Cell Biol 2016; 26(5):313-26; https://doi.org/10.1016/j.tcb.2016.01.004
- Lazar MA. Developmental biology. How now, brown fat?. Science 2008; 321:1048–9; https://doi.org/10.1126/science.1164094
- Ussar S, Lee KY, Dankel SN, Boucher J, Haering MF, Kleinridders A, Thomou T, Xue R, Macotela Y, Cypess AM, et al. ASC-1, PAT2, and P2RX5 are cell surface markers for white, beige, and brown adipocytes. Sci Transl Med 2014; 6:247ra103; PMID: 25080478; https://doi.org/10.1126/scitranslmed.3008490
- Chen Z, Kennedy DJ, Wake KA, Zhuang L, Ganapathy V, Thwaites DT. Structure, tissue expression pattern, and function of the amino acid transporter rat PAT2. Biochem Biophys Res Commun 2003; 304:747–54; PMID: 12727219; https://doi.org/10.1016/S0006-291X(03)00648-X
- Symonds ME. Brown adipose tissue growth and development. Scientifica 2013; 2013:305763; PMID: 24278771; https://doi.org/10.1155/2013/305763
- Gao YJ. Dual modulation of vascular function by perivascular adipose tissue and its potential correlation with adiposity/lipoatrophy-related vascular dysfunction. Curr Pharm Des 2007; 13:2185–92; PMID: 17627551; https://doi.org/10.2174/138161207781039634
- Cousin B, Cinti S, Morroni M, Raimbault S, Ricquier D, Penicaud L, Casteilla L. Occurrence of brown adipocytes in rat white adipose tissue: molecular and morphological characterization. J Cell Sci 1992; 103(Pt 4):931–42. PMID: 1362571
- Bull MJ, Williams AS, Mecklenburgh Z, Calder CJ, Twohig JP, Elford C, Evans BA, Rowley TF, Slebioda TJ, Taraban VY, et al. The Death Receptor 3-TNF-like protein 1A pathway drives adverse bone pathology in inflammatory arthritis. J Exp Med 2008; 205:2457–64; PMID: 18824582; https://doi.org/10.1084/jem.20072378
- Nowell MA, Williams AS, Carty SA, Scheller J, Hayes AJ, Jones GW, Richards PJ, Slinn S, Ernst M, Jenkins BJ, et al. Therapeutic targeting of IL-6 trans signaling counteracts STAT3 control of experimental inflammatory arthritis. J Immunol 2009; 182:613–22; https://doi.org/10.4049/jimmunol.182.1.613
- Williams AS, Mizuno M, Richards PJ, Holt DS, Morgan BP. Deletion of the gene encoding CD59a in mice increases disease severity in a murine model of rheumatoid arthritis. Arthritis Rheum 2004; 50:3035–44; PMID: 15457473; https://doi.org/10.1002/art.20478
- Tanaka M, Ikeda K, Suganami T, Komiya C, Ochi K, Shirakawa I, Hamaguchi M, Nishimura S, Manabe I, Matsuda T, et al. Macrophage-inducible C-type lectin underlies obesity-induced adipose tissue fibrosis. Nat Commun 2014; 5:4982; PMID: 25236782; https://doi.org/10.1038/ncomms5982
- Kelley EE, Baust J, Bonacci G, Golin-Bisello F, Devlin JE, St Croix CM, Watkins SC, Gor S, Cantu-Medellin N, Weidert ER, et al. Fatty acid nitroalkenes ameliorate glucose intolerance and pulmonary hypertension in high-fat diet-induced obesity. Cardiovasc Res 2014; 101:352–63; PMID: 24385344; https://doi.org/10.1093/cvr/cvt341
- Martinez-Martinez E, Calvier L, Rossignol P, Rousseau E, Fernandez-Celis A, Jurado-Lopez R, Laville M, Cachofeiro V, Lopez-Andres N. Galectin-3 inhibition prevents adipose tissue remodelling in obesity. Int J Obes (Lond) 2005; 2016.
- Brand DD, Latham KA, Rosloniec EF. Collagen-induced arthritis. Nat Protoc 2007; 2:1269–75; PMID: 17546023; https://doi.org/10.1038/nprot.2007.173
- Kim SA, Park SH, Jo SH, Park KH, Kim HS, Han SJ, Park WJ, Ha JW. Alterations of carotid arterial mechanics preceding the wall thickening in patients with hypertension. Atherosclerosis 2016; 248:84–90; PMID: 26990725; https://doi.org/10.1016/j.atherosclerosis.2016.02.017
- Ryu Y, Yoshida K, Suzuki Y, Nakadate M, Umehara I, Tomita M, Shibuya H. Long-term changes of aortic 18F-FDG uptake and calcification in health-screening subjects. Ann Nucl Med 2013; 27:239–46; PMID: 23264081; https://doi.org/10.1007/s12149-012-0679-z
- Haskett D, Johnson G, Zhou A, Utzinger U, Vande Geest J. Microstructural and biomechanical alterations of the human aorta as a function of age and location. Biomech Model Mechanobiol 2010; 9:725–36; PMID: 20354753; https://doi.org/10.1007/s10237-010-0209-7
- Head RJ. Hypernoradrenergic innervation: its relationship to functional and hyperplastic changes in the vasculature of the spontaneously hypertensive rat. Blood Vessels 1989; 26:1–20. PMID: 2540863
- Berbee JF, Boon MR, Khedoe PP, Bartelt A, Schlein C, Worthmann A, Kooijman S, Hoeke G, Mol IM, John C, et al. Brown fat activation reduces hypercholesterolaemia and protects from atherosclerosis development. Nat Commun 2015; 6:6356; PMID: 25754609; https://doi.org/10.1038/ncomms7356
- Bartelt A, Heeren J. Adipose tissue browning and metabolic health. Nat Rev Endocrinol 2014; 10:24–36; PMID: 24146030; https://doi.org/10.1038/nrendo.2013.204
- Al-Ansari S, Zeebregts CJ, Slart RH, Peppelenbosch M, Tio RA. Galectins in atherosclerotic disease. Trends Cardiovasc Med 2009; 19:164–9; PMID: 20005476; https://doi.org/10.1016/j.tcm.2009.10.001
- de Boer RA, van Veldhuisen DJ, Gansevoort RT, Muller Kobold AC, van Gilst WH, Hillege HL, Bakker SJ, van der Harst P. The fibrosis marker galectin-3 and outcome in the general population. J Intern Med 2012; 272:55–64; PMID: 22026577; https://doi.org/10.1111/j.1365-2796.2011.02476.x
- Madrigal-Matute J, Lindholt JS, Fernandez-Garcia CE, Benito-Martin A, Burillo E, Zalba G, Beloqui O, Llamas-Granda P, Ortiz A, Egido J, et al. Galectin-3, a biomarker linking oxidative stress and inflammation with the clinical outcomes of patients with atherothrombosis. J Am Heart Assoc 2014; 3:pii: ee000785; https://doi.org/10.1161/JAHA.114.000785
- Chau YY, Bandiera R, Serrels A, Martinez-Estrada OM, Qing W, Lee M, Slight J, Thornburn A, Berry R, McHaffie S, et al. Visceral and subcutaneous fat have different origins and evidence supports a mesothelial source. Nat Cell Biol 2014; 16:367–75; PMID: 24609269; https://doi.org/10.1038/ncb2922
- Karastergiou K, Fried SK. Multiple adipose depots increase cardiovascular risk via local and systemic effects. Curr Atheroscler Rep 2013; 15:361; PMID: 23982264; https://doi.org/10.1007/s11883-013-0361-5
- Hoffstedt J, Arner E, Wahrenberg H, Andersson DP, Qvisth V, Lofgren P, Ryden M, Thorne A, Wiren M, Palmer M, et al. Regional impact of adipose tissue morphology on the metabolic profile in morbid obesity. Diabetologia 2010; 53:2496–503; PMID: 20830466; https://doi.org/10.1007/s00125-010-1889-3
- Farb MG, Gokce N. Visceral adiposopathy: a vascular perspective. Horm Mol Biol Clin Investig 2015; 21:125–36; PMID: 25781557; https://doi.org/10.1515/hmbci-2014-0047
- Acosta JR, Douagi I, Andersson DP, Backdahl J, Ryden M, Arner P, Laurencikiene J. Increased fat cell size: a major phenotype of subcutaneous white adipose tissue in non-obese individuals with type 2 diabetes. Diabetologia 2016; 59:560–70; PMID: 26607638; https://doi.org/10.1007/s00125-015-3810-6
- Eriksson-Hogling D, Andersson DP, Backdahl J, Hoffstedt J, Rossner S, Thorell A, Arner E, Arner P, Ryden M. Adipose tissue morphology predicts improved insulin sensitivity following moderate or pronounced weight loss. Int J Obes (Lond) 2005 2015; 39:893–8; https://doi.org/10.1038/ijo.2015.18
- Van Gaal LF, Mertens IL, De Block CE. Mechanisms linking obesity with cardiovascular disease. Nature 2006; 444:875–80; PMID: 17167476; https://doi.org/10.1038/nature05487
- Taube A, Schlich R, Sell H, Eckardt K, Eckel J. Inflammation and metabolic dysfunction: links to cardiovascular diseases. Am J Physiol Heart Circ Physiol 2012; 302:H2148–65; PMID: 22447947; https://doi.org/10.1152/ajpheart.00907.2011
- Williams JO, Wang ECY, Lang D, Williams AS. Characterization of death receptor 3-dependent aortic changes during inflammatory arthritis. Pharmacol Res Perspect 2016; 4:e00240; https://doi.org/10.1002/prp2.240
- Moos MP, John N, Grabner R, Nossmann S, Gunther B, Vollandt R, Funk CD, Kaiser B, Habenicht AJ. The lamina adventitia is the major site of immune cell accumulation in standard chow-fed apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2005; 25:2386–91; PMID: 16179593; https://doi.org/10.1161/01.ATV.0000187470.31662.fe
- Ameer OZ, Salman IM, Avolio AP, Phillips JK, Butlin M. Opposing changes in thoracic and abdominal aortic biomechanical properties in rodent models of vascular calcification and hypertension. Am J Physiol Heart Circ Physiol 2014; 307:H143–51; PMID: 24838503; https://doi.org/10.1152/ajpheart.00139.2014
- Hong HC, Hwang SY, Park S, Ryu JY, Choi HY, Yoo HJ, Seo JA, Kim SG, Kim NH, Baik SH, et al. Implications of Pericardial, Visceral and Subcutaneous Adipose Tissue on Vascular Inflammation Measured Using 18FDG-PET/CT. PLoS One 2015; 10:e0135294; PMID: 26270050; https://doi.org/10.1371/journal.pone.0135294
- Samaras K, Botelho NK, Chisholm DJ, Lord RV. Subcutaneous and visceral adipose tissue gene expression of serum adipokines that predict type 2 diabetes. Obesity 2010; 18:884–9; PMID: 20019678; https://doi.org/10.1038/oby.2009.443
- Pou KM, Massaro JM, Hoffmann U, Vasan RS, Maurovich-Horvat P, Larson MG, Keaney JF, Jr., Meigs JB, Lipinska I, Kathiresan S, et al. Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the Framingham Heart Study. Circulation 2007; 116:1234–41; PMID: 17709633; https://doi.org/10.1161/CIRCULATIONAHA.107.710509
- Fox CS, Massaro JM, Hoffmann U, Pou KM, Maurovich-Horvat P, Liu CY, Vasan RS, Murabito JM, Meigs JB, Cupples LA, et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation 2007; 116:39–48; PMID: 17576866; https://doi.org/10.1161/CIRCULATIONAHA.106.675355
- Lehman SJ, Massaro JM, Schlett CL, O'Donnell CJ, Hoffmann U, Fox CS. Peri-aortic fat, cardiovascular disease risk factors, and aortic calcification: the Framingham Heart Study. Atherosclerosis 2010; 210:656–61; PMID: 20152980; https://doi.org/10.1016/j.atherosclerosis.2010.01.007
- Lu G, Zhang R, Geng S, Peng L, Jayaraman P, Chen C, Xu F, Yang J, Li Q, Zheng H, et al. Myeloid cell-derived inducible nitric oxide synthase suppresses M1 macrophage polarization. Nat Commun 2015; 6:6676; PMID: 25813085; https://doi.org/10.1038/ncomms7676
- Sakamoto T, Takahashi N, Sawaragi Y, Naknukool S, Yu R, Goto T, Kawada T. Inflammation induced by RAW macrophages suppresses UCP1 mRNA induction via ERK activation in 10T1/2 adipocytes. Am J Physiol Cell Physiol 2013; 304:C729–38; PMID: 23302779; https://doi.org/10.1152/ajpcell.00312.2012
- Lacasa D, Taleb S, Keophiphath M, Miranville A, Clement K. Macrophage-secreted factors impair human adipogenesis: involvement of proinflammatory state in preadipocytes. Endocrinology 2007; 148:868–77; PMID: 17082259; https://doi.org/10.1210/en.2006-0687
- Fitzgibbons TP, Kogan S, Aouadi M, Hendricks GM, Straubhaar J, Czech MP. Similarity of mouse perivascular and brown adipose tissues and their resistance to diet-induced inflammation. Am J Physiol Heart Circ Physiol 2011; 301:H1425–37; PMID: 21765057; https://doi.org/10.1152/ajpheart.00376.2011
- Padilla J, Jenkins NT, Vieira-Potter VJ, Laughlin MH. Divergent phenotype of rat thoracic and abdominal perivascular adipose tissues. Am J Physiol Regul Integr Comp Physiol 2013; 304:R543–52; PMID: 23389108; https://doi.org/10.1152/ajpregu.00567.2012
- Verhagen SN, Visseren FL. Perivascular adipose tissue as a cause of atherosclerosis. Atherosclerosis 2011; 214:3–10; PMID: 20646709; https://doi.org/10.1016/j.atherosclerosis.2010.05.034
- Nayor M, Wang N, Larson MG, Vasan RS, Levy D, Ho JE. Circulating Galectin-3 is associated with cardiometabolic disease in the community. J Am Heart Assoc 2016; 5:e002347; https://doi.org/10.1161/JAHA.115.002347
- Maiolino G, Rossitto G, Pedon L, Cesari M, Frigo AC, Azzolini M, Plebani M, Rossi GP. Galectin-3 predicts long-term cardiovascular death in high-risk patients with coronary artery disease. Arterioscler Thromb Vasc Biol 2015; 35:725–32; PMID: 25614283; https://doi.org/10.1161/ATVBAHA.114.304964
- Ohshima S, Kuchen S, Seemayer CA, Kyburz D, Hirt A, Klinzing S, Michel BA, Gay RE, Liu FT, Gay S, et al. Galectin 3 and its binding protein in rheumatoid arthritis. Arthritis Rheum 2003; 48:2788–95; PMID: 14558084; https://doi.org/10.1002/art.11287